Licensed Practical Nurse in Flora, IL Accepting Medicare

7 Licensed Practical Nurse nurses found. Showing 1 - 7

Lisa Jo Davis, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 E North Ave, Flora, IL 62839 Phone: 618-662-8386    Fax: 618-662-4338

Mrs. Kimberly Ann Greenwalt, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 E N Ave, Clay Medical Center, Flora, IL 62839 Phone: 618-662-8386    Fax: 618-662-4338

Betty M Harrelson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 E North Ave, Flora, IL 62839 Phone: 618-662-8386

Mrs. Ronna Lee Schoonover, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 E N Avenue, Clay Medical Center, Flora, IL 62839 Phone: 618-662-8386    Fax: 618-662-4338

Jennifer Smith, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 E North Ave, Flora, IL 62839 Phone: 618-662-8386

Carrie Dawn Spitzner, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 E North Ave, Flora, IL 62839 Phone: 618-662-8386

Mary Sachs, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 E North Ave, Flora, IL 62839 Phone: 618-662-8386

News Archive

Researchers report promising biotherapeutics for obesity and related medical complications

The research teams at the University of Hong Kong led by Professor Xuechen LI from the Research Division for Chemistry and Department of Chemistry, and Professor Yu WANG from the Department of Pharmacology and Pharmacy, reported a synthetic biotherapeutics with promising anti-tumor, insulin sensitising and hepatoprotective activities in the Journal of the American Chemical Society.

New report highlights progress made in preventable maternal deaths

Maternal mortality has fallen by 44% since 1990, United Nations agencies and the World Bank Group reported today.

NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial

NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.

Does physical activity provide a molecular key to longevity?

Fitness and physical exercise are among the most neglected means to improve prognosis. They are the healthiest cardiovascular intervention. Even cardiologists focus on pharmacological treatment and evaluate classical risk factors without asking about daily exercise or objective measures of physical capacity. It is surprising considering the strong data that underscores the survival benefit of regular exercise training.

Read more Medical News

› Verified 4 days ago